The Cell Cycle Regulator 14-3-3σ Opposes and Reverses Cancer Metabolic Reprogramming
Liem Phan,Ping-Chieh Chou,Guermarie Velazquez-Torres,Ismael Samudio,Kenneth Parreno,Yaling Huang,Chieh Tseng,Thuy Vu,Chris Gully,Chun-Hui Su,Edward Wang,Jian Chen,Hyun-Ho Choi,Enrique Fuentes-Mattei,Ji-Hyun Shin,Christine Shiang,Brian Grabiner,Marzenna Blonska,Stephen Skerl,Yiping Shao,Dianna Cody,Jorge Delacerda,Charles Kingsley,Douglas Webb,Colin Carlock,Zhongguo Zhou,Yun-Chih Hsieh,Jaehyuk Lee,Andrew Elliott,Marc Ramirez,Jim Bankson,John Hazle,Yongxing Wang,Lei Li,Shaofan Weng,Nibal Rizk,Yu Ye Wen,Xin Lin,Hua Wang,Huamin Wang,Aijun Zhang,Xuefeng Xia,Yun Wu,Mouhammed Habra,Wei Yang,Lajos Pusztai,Sai-Ching Yeung,Mong-Hong Lee
DOI: https://doi.org/10.1038/ncomms8530
IF: 16.6
2015-01-01
Nature Communications
Abstract:Extensive reprogramming of cellular energy metabolism is a hallmark of cancer. Despite its importance, the molecular mechanism controlling this tumour metabolic shift remains not fully understood. Here we show that 14-3-3σ regulates cancer metabolic reprogramming and protects cells from tumorigenic transformation. 14-3-3σ opposes tumour-promoting metabolic programmes by enhancing c-Myc poly-ubiquitination and subsequent degradation. 14-3-3σ demonstrates the suppressive impact on cancer glycolysis, glutaminolysis, mitochondrial biogenesis and other major metabolic processes of tumours. Importantly, 14-3-3σ expression levels predict overall and recurrence-free survival rates, tumour glucose uptake and metabolic gene expression in breast cancer patients. Thus, these results highlight that 14-3-3σ is an important regulator of tumour metabolism, and loss of 14-3-3σ expression is critical for cancer metabolic reprogramming. We anticipate that pharmacologically elevating the function of 14-3-3σ in tumours could be a promising direction for targeted anticancer metabolism therapy development in future.